Skip to main content

Table 1 Whole-exome sequencing mutation data analyzed in this study

From: Identification of a small mutation panel of coding sequences to predict the efficacy of immunotherapy for lung adenocarcinoma

Patient characteristicsTCGAMatthew [5]Rizvi [4]
No. (%)No. (%)No. (%)
Histology
 Adenocarcinoma4865929
Age (years)
 No less than 65223 (46)29 (50)10 (34)
 Less than 65263 (54)30 (50)19 (66)
Sex
 Male222 (46)22 (37)13 (45)
 Female264 (54)37 (63)16 (55)
Smoking status
 Never13 (22)5 (17)
 Former/light38 (64)18 (62)
 Current/heavy8 (14)6 (21)
Stage
 I263 (54)
 II117 (24)
 IIIA70 (14)
 IIIB–IV36 (7)59 (100)29 (100)
PFS-status
 Progression40 (68)20 (69)
 Progression-free19 (32)9 (31)
Percentage of tumour cells
 Known433 (89)
 Unknown53 (11)
Average percentage of tumour cells78.76